Circulating Tumor Cell Is a Clinical Indicator of Pretransplant Radiofrequency Ablation for Patients with Hepatocellular Carcinoma

INTRODUCTION: It is of great significance to confirm reliable indicators for the guidance of pretransplant radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC). In this study, we aim to investigate whether circulating tumor cell (CTC) status is a clinical indicator for RFA before liver t...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Zhitao, Wang, Tielong, Chen, Chuanbao, Hong, Xitao, Yu, Jia, Ma, Yihao, Guo, Yiwen, Huang, Changjun, He, Xiaoshun, Ju, Weiqiang, Chen, Maogen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548160/
https://www.ncbi.nlm.nih.gov/pubmed/34712326
http://dx.doi.org/10.1155/2021/7776389

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548160/
https://www.ncbi.nlm.nih.gov/pubmed/34712326
http://dx.doi.org/10.1155/2021/7776389

Ejemplares similares